Vestagen Technical Textiles bags $3.3mn bridge financing
September 11, 2015 - United States Of America
US based Vestagen Technical Textiles has completed a $3.3 million convertible note bridge financing led by Advent Life Sciences and Health Quest Capital and other existing Vestagen investors.
“The funds will support ongoing commercialization of Vestex, the first in a new class of active barrier technologies that combines fluid repellent, antimicrobial and breathability properties,” it said in a press release.
According to the company, Vestex is the only daily-use fabric proven in a hospital setting to reduce harmful contaminants on garments.
“Vestex protected uniforms are designed to increase healthcare worker and patient safety by reducing the risk that pathogens and other contaminants will be carried by workers’ attire,” it added.
“The unique ability of Vestex to transform everyday uniforms into apparel that helps guard workers and patients from the contaminants has earned it an exclusive endorsement from the American Hospital Association,” said CEO Dal Pfost.
“This bridge financing will enable us to expand marketing initiatives we recently launched that offer avenues for highly effective engagement with prospective customers,” Pfost too added.
Vestex active barrier fabric incorporates three powerful technologies; a highly repellent fluid barrier, a durable antimicrobial and a wicking technology that ensures wearer comfort.
The company further added that Vestex is suitable for a variety of applications, including healthcare, public safety and athletic use.
Contaminated clothing is a known carrier of bacteria, which contributes to US government data showing that healthcare workers have among the highest rates of illness and injury of any occupation.
Contamination with multi-drug resistant organisms such as MRSA contributes to the spread of healthcare-associated infections and puts workers and patients at risk.
A peer-reviewed published study confirmed that Vestex protected uniforms demonstrated a statistically significant reduction of almost 100 per cent in MRSA organisms compared to traditional non-protective scrub uniforms.
Vestagen Technical Textiles develops and markets advanced performance
textile products and technologies. (AR)